slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 40,111-40,140
Pages 1,371
Rows per page 30
Component
40,111-40,140 of 41,127
24
Standard financial disclosure slide for non-GAAP metrics.Earthstone Energy | Investor Presentation Deck | 26 slides · Earthstone Energy
Pitch deck Investor relations 1 hit
14
Includes geological cross-section diagrams and a map inset showing the seismic line location.Elephant Oil | FWP Presentation Deck | 27 slides · Elephant Oil
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses external validation (Wood Mackenzie) to frame the regional potential for Elephant Oil's assets.Elephant Oil | FWP Presentation Deck | 27 slides · Elephant Oil
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
02
Energy Company of Parana | Mergers and Acquisitions Presentation Deck | 10 slidesEnergy Company of Parana | Mergers and Acquisitions Presentation Deck | 10 slides · COPEL
Conference presentation Investment bank 1 hit
09
The chart displays a large number of overlapping lines representing different securitization pools, with a legend on the right.Ford Credit | FWP Presentation Deck | 13 slides · Ford Credit
Conference presentation Investor relations 1 hit
02
Heliogen | Investor Day Presentation Deck | 80 slidesHeliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
08
The slide uses a visual metaphor of the technology integrated into an existing industrial landscape to demonstrate the 'on-site' nature of the solution.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
02
Idacorp | Investor Presentation Deck | 9 slidesIdacorp | Investor Presentation Deck | 9 slides · IDACORP
Conference presentation Investor relations Beat · Attention1 hit
07
The slide highlights a trend of increasing load growth forecasts over time.Idacorp | Investor Presentation Deck | 9 slides · IDACORP
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
02
Imara | Mergers and Acquisitions Presentation Deck | 45 slidesImara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
06
Includes headshots for leadership team and lists for board, advisors, and investors.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Team1 hit
11
Includes scatter plot for MMR correlation and bar chart for therapeutic index comparison.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
12
The slide outlines three strategic pillars (Drive Deeper Responses, Improve Tolerability, Enhance Safety & Convenience) and maps them to specific clinical development programs.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
13
Uses a before-after-bridge structure to contrast market limitations with product advantages.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
16
Includes a list of abbreviations at the bottom.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
17
Imara | Mergers and Acquisitions Presentation Deck | 45 slidesImara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
19
Includes a timeline of key drug approvals and a survival probability chart.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
20
The slide uses a split-screen layout to contrast clinical challenges with the rationale for treatment switching.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
22
Includes clinical trial data and resistance mutation analysis.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
23
The slide uses a split-screen layout to contrast current market realities with the company's vision, supported by a survival curve and a patient outcome pie chart.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
26
Includes structural biology diagrams of BCR-ABL protein domains and a table comparing binding conformations.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
29
The slide uses a scatter plot for efficacy correlation and a bar chart for safety margin comparison.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
30
The slide uses a process-oriented layout to show the progression of clinical trials.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
34
The slide contrasts established therapies with investigational ones, emphasizing the lack of selective TKIs and the resulting toxicity issues.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
35
The slide highlights a gap in the market for a selective, irreversible TKI for brain metastases.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
40
Data shows ELVN-002 efficacy and safety profile compared to Tucatinib and Poziotinib.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
41
The slide compares efficacy (BLI signal) and PK (concentration over time) to demonstrate superior potency of ELVN-002 at lower exposures.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
43
Includes a line chart showing concentration over time and a table summarizing safety margin folds at different doses.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
44
Uses a process-oriented layout to show progression of clinical trials.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
02
Innovative Eyewear | Investor Presentation Deck | 21 slidesInnovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations 1 hit